MARIMED INC.·4

Mar 2, 4:12 PM ET

Shaw Timothy 4

Research Summary

AI-generated summary

Updated

MariMed (MRMD) COO Timothy Shaw Receives 65,000 RSU Shares

What Happened
Timothy Shaw, Chief Operating Officer of MariMed, had 65,000 restricted stock units (RSUs convert/derivatives) vest and convert into common stock on March 1, 2026. No cash exercise price was paid ($0.00 per share). The company withheld 22,523 shares to satisfy tax withholding obligations (reported value ~$1,910), leaving a net delivery of 42,477 shares to Shaw.

Key Details

  • Transaction date: March 1, 2026; Form filed March 2, 2026 (timely).
  • Actions reported: conversion/exercise of derivative (RSU conversion, code M) for 65,000 shares; tax withholding (code F) of 22,523 shares at $0.08/share for $1,910.
  • Net shares delivered to Shaw after withholding: 42,477 (65,000 − 22,523).
  • Shares owned after transaction: not specified in the provided Form 4 summary.
  • Relevant footnotes: (F1/F2) RSUs convert one-for-one and shares were withheld to cover taxes; (F4) these RSUs were granted 9/1/2023 and remaining shares under that grant vest 9/1/2026; (F3) some shares are held in an irrevocable trust for the reporting person’s children and the reporting person disclaims beneficial ownership of the trust holdings.

Context
This was a vesting/conversion of RSUs (no cash outlay), with routine withholding to cover tax obligations — a common administrative event rather than an open-market buy or sell. Such tax-withholding dispositions generally do not signal a change in conviction about the company.